TrialThe Journal of infectious diseases2024

Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing Flu-Like Reactions During Treatment of Latent Tuberculosis Infection.

Ruth N Moro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.